ESPR
Esperion Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.18
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.66x
- Price / sales
- 1.96x
- Price / cash flow
- -45.06x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.89x
- EV / EBITDA
- 30.25x
- EV / EBIT
- 15.93x
- Market cap
- $819.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026